Price alert —
Sign in to get a one-time email the moment VTRS crosses your price. Free accounts included.
Sign in / create a free accountViatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS last traded at $17.35, up 2.1% on the day; that's in the upper part of its 52-week range ($12.71–$17.67). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.
The next scheduled earnings report (2026-08-06) is the biggest known catalyst on the calendar, and after a strong run, watch whether the price can hold its gains on quieter days.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
KC1 upper, +1.51 ATR from EMA21 — no notable pattern
- · Aligned with weak uptrend
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
- · KC1 upper stretch — light pop
- · Stochastic bear cross in overbought
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
Our cash-flow model pegs fair value near $29.98 (fair range $30–$38); today's price leaves a +44% cushion below that estimate. The model's verdict is “Deep value” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ⚠ Debt exceeds cash
- ⚠ Quick ratio 0.70 (fragile)
- ⚠ Negative retained earnings
- ⚠ Inventory growing faster than revenue
Price implies ~1% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
VTRS is a $20.2 billion company, the stock is trading near the top of its 52-week range.
Options idea
See more →Earnings
See more →- Last reported
- 2026-05-07
- EPS (act / est)
- 0.59 / 0.50
- Surprise
- +17.5%
- Next report
- 2026-08-06
About
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex …